According to Yoo et al., metastatic brain tumors show increased e-cadherin levels, while low levels of e-cadherin expression in non-small cell lung carcinoma corresponded with increased risk for brain metastases [11]. This evidence concerns the gene CDH1 and non-small cell lung carcinoma.